El Fassi, D., Banga, J. P., Gilbert, J. A., Padoa, C., Hegedüs, L., & Nielsen, C. H. (2009). Treatment of Graves' disease with rituximab specifically reduces the production of thyroid stimulating autoantibodies. Clinical immunology (Orlando, Fla.), 130(3), 252. https://doi.org/10.1016/j.clim.2008.09.007
Chicago ZitierstilEl Fassi, Daniel, J Paul Banga, Jacqueline A. Gilbert, Carolyn Padoa, Laszlo Hegedüs, und Claus H. Nielsen. "Treatment of Graves' Disease with Rituximab Specifically Reduces the Production of Thyroid Stimulating Autoantibodies." Clinical Immunology (Orlando, Fla.) 130, no. 3 (2009): 252. https://dx.doi.org/10.1016/j.clim.2008.09.007.
MLA ZitierstilEl Fassi, Daniel, et al. "Treatment of Graves' Disease with Rituximab Specifically Reduces the Production of Thyroid Stimulating Autoantibodies." Clinical Immunology (Orlando, Fla.), vol. 130, no. 3, 2009, p. 252.